1. Chu MJ, Dare AJ, Phillips AR, Bartlett AS. Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review. J Gastrointest Surg 2015;19:1713- 1724.
2. Imber CJ, St Peter SD, Lopez I, Guiver L, Friend PJ. Current practice regarding the use of fatty livers: a trans-Atlantic survey. Liver Transpl 2002;8:545-549.
3. Doyle MB, Vachharajani N, Wellen JR, Anderson CD, Lowell JA, Shenoy S et al. Short- and long-term outcomes after steatotic liver transplantation. Archives of surgery (Chicago, Ill : 1960) 2010;145:653-660.
4. Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 2017;377:13-27.
5. Mavrogiannaki AN, Migdalis IN. Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. Int J Endocrinol 2013;2013:450639.
6. Wong TC, Fung JY, Chok KS, Cheung TT, Chan AC, Sharr WW et al. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors. Liver Transpl 2016;22:226-236.
7. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007;246:940-946; discussion 946-948.
8. Bedogni G, Nobili V, Tiribelli C. Epidemiology of fatty liver: an update. World J Gastroenterol 2014;20:9050-9054.
9. Delzenne NM, Hernaux NA, Taper HS. A new model of acute liver steatosis induced in rats by fasting followed by refeeding a high carbohydrate-fat free diet. Biochemical and morphological analysis. J Hepatol 1997;26:880-885.
10. Rogers AE, Newberne PM. Animal model: fatty liver and cirrhosis in lipotrope- deficient male rats. The American journal of pathology 1973;73:817-820.
11. He S, Rehman H, Wright GL, Zhong Z. Inhibition of inducible nitric oxide synthase prevents mitochondrial damage and improves survival of steatotic partial liver grafts. Transplantation 2010;89:291-298.
12. Anderson CD, Upadhya G, Conzen KD, Jia J, Brunt EM, Tiriveedhi V et al. Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts. Liver Transpl 2011;17:189-200.
13. Okamura Y, Hata K, Tanaka H, Hirao H, Kubota T, Inamoto O et al. Impact of Subnormothermic Machine Perfusion Preservation in Severely Steatotic Rat Livers: A Detailed Assessment in an Isolated Setting. Am J Transplant 2017;17:1204-1215.
14. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979;28:47- 50.
15. Liu T, Freise CE, Ferrell L, Ascher NL, Roberts JP. A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats. Transplantation 1992;54:179-180.
16. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. The Journal of biological chemistry 1957;226:497-509.
17. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
18. Yagi S, Doorschodt BM, Afify M, Klinge U, Kobayashi E, Uemoto S et al. Improved preservation and microcirculation with POLYSOL after partial liver transplantation in rats. J Surg Res 2011;167:e375-383.
19. Wasserstein RL, Lazar NA. The ASA Statement on p-Values: Context, Process, and Purpose. The American Statistician 2016;70:129-133.
20. Wasserstein RL, Schirm AL, Lazar NA. Moving to a World Beyond “p < 0.05”. The American Statistician 2019;73:1-19.
21. Hata K, Tolba RH, Wei L, Doorschodt BM, Buttner R, Yamamoto Y et al. Impact of polysol, a newly developed preservation solution, on cold storage of steatotic rat livers. Liver Transpl 2007;13:114-121.
22. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. The Journal of biological chemistry 1988;263:2998-3004.
23. Yao ZM, Vance DE. Head group specificity in the requirement of phosphatidylcholine biosynthesis for very low density lipoprotein secretion from cultured hepatocytes. The Journal of biological chemistry 1989;264:11373-11380.
24. Rinella ME, Green RM. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 2004;40:47-51.
25. Oz HS, Chen TS, Neuman M. Methionine deficiency and hepatic injury in a dietary steatohepatitis model. Dig Dis Sci 2008;53:767-776.
26. Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P et al. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature 2016;531:253-257.
27. Selzner N, Selzner M, Jochum W, Amann-Vesti B, Graf R, Clavien PA. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J Hepatol 2006;44:694-701.
28. Ijaz S, Yang W, Winslet MC, Seifalian AM. Impairment of hepatic microcirculation in fatty liver. Microcirculation 2003;10:447-456.
29. Cheng Q, Ng KT, Xu A, Li CX, Liu XB, Guo DY et al. The roles of lipocalin-2 in small-for-size fatty liver graft injury. Ann Surg 2014;260:1062-1072.
30. El-Badry AM, Moritz W, Contaldo C, Tian Y, Graf R, Clavien PA. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology 2007;45:855-863.
31. Kuroda S, Tashiro H, Igarashi Y, Tanimoto Y, Nambu J, Oshita A et al. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver. J Hepatol 2012;56:146-152.
32. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 2004;40:386-393.
33. Sorensen KK, Simon-Santamaria J, McCuskey RS, Smedsrod B. Liver Sinusoidal Endothelial Cells. Compr Physiol 2015;5:1751-1774.
34. Abu-Amara M, Yang SY, Tapuria N, Fuller B, Davidson B, Seifalian A. Liver ischemia/reperfusion injury: processes in inflammatory networks--a review. Liver Transpl 2010;16:1016-1032.
35. Pulitano C, Joseph D, Sandroussi C, Verran D, Ho P, Debiasio A et al. Postreperfusion microcirculatory derangements after liver transplantation: Relationship to hemodynamics, serum mediators, and outcome. Liver Transpl 2017;23:527-536.
36. Liu B, Qian JM. Cytoprotective role of heme oxygenase-1 in liver ischemia reperfusion injury. International journal of clinical and experimental medicine 2015;8:19867-19873.
37. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 2002;37:56-62.
38. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999;104:1631-1639.
39. Ross D, Siegel D. Functions of NQO1 in Cellular Protection and CoQ10 Metabolism and its Potential Role as a Redox Sensitive Molecular Switch. Front Physiol 2017;8:595.
40. Gracia-Sancho J, Garcia-Caldero H, Hide D, Marrone G, Guixe-Muntet S, Peralta C et al. Simvastatin maintains function and viability of steatotic rat livers procured for transplantation. J Hepatol 2013;58:1140-1146.
41. Yagi S, Nagai K, Kadaba P, Afify M, Teramukai S, Uemoto S et al. A novel organ preservation for small partial liver transplantations in rats: venous systemic oxygen persuf fl ation with nitric oxide gas. Am J Transplant 2013;13:222-228.
42. Boteon YL, Boteon A, Attard J, Mergental H, Mirza DF, Bhogal RH et al. Ex situ machine perfusion as a tool to recondition steatotic donor livers: Troublesome features of fatty livers and the role of defatting therapies. A systematic review. Am J Transplant 2018;18:2384-2399.
43. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006;43:S31-44.
44. Sanches SC, Ramalho LN, Augusto MJ, da Silva DM, Ramalho FS. Nonalcoholic Steatohepatitis: A Search for Factual Animal Models. Biomed Res Int 2015;2015:574832.